4,000
Participants
Start Date
September 26, 2024
Primary Completion Date
September 30, 2030
Study Completion Date
December 31, 2030
Tenecteplase
Thrombolytic
NOT_YET_RECRUITING
The George Institute for Global Health, Sydney
RECRUITING
Royal Prince Alfred Hospital, Sydney
RECRUITING
Monash University (Box Hill), Melbourne
NOT_YET_RECRUITING
Medicine Hat Regional Hospital, Medicine Hat
NOT_YET_RECRUITING
Red Deer Regional Hospital, Red Deer
RECRUITING
University of Alberta, Edmonton
NOT_YET_RECRUITING
Kelowna Regional Hospital, Kelowna
NOT_YET_RECRUITING
Royal Columbian Hospital, New Westminster
RECRUITING
University of British Columbia, Vancouver
NOT_YET_RECRUITING
Brandon Regional Hospital, Brandon
RECRUITING
University of Manitoba - Winnipeg Health Science Centre, Winnipeg
NOT_YET_RECRUITING
Queen Elizabeth II Health Science Center (Halifax), Halifax
RECRUITING
Health Sciences North Horizon Sante-Nord, Greater Sudbury
RECRUITING
McMaster University Hamilton Health Sciences Centre, Hamilton
NOT_YET_RECRUITING
Kingston General Hospital, Kingston
NOT_YET_RECRUITING
Lawson Health Research Institute- London, London
RECRUITING
University of Ottawa, Ottawa
RECRUITING
St. Michael's Hospital, Toronto
RECRUITING
Sunnybrook Health Science Centre, Toronto
RECRUITING
Queen Elizabeth Hospital (PEI), Charlottetown
NOT_YET_RECRUITING
Centre Hospitalier de l'Université de Montréal (CHUM), Montreal
NOT_YET_RECRUITING
CIUSSS de l'Estrie - CHUS Fleurimont Hôpital (Sherbrooke), Sherbrooke
RECRUITING
Royal University Hospital, Saskatoon
RECRUITING
University of Calgary, Calgary
The George Institute for Global Health, Australia
OTHER
University of Calgary
OTHER